KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia

PLoS ONE

Volumn 12, Issue 9, 2017, Pages

  Juárez, Miriam ^a   Egoavil, Cecilia ^a   Rodríguez Soler, María ^a   Hernández Illán, Eva ^a   Guarinos, Carla ^a   García Martínez, Araceli ^a   Alenda, Cristina ^a   Giner Calabuig, Mar ^a   Murcia, Oscar ^a   Mangas, Carolina ^a   Payá, Artemio ^a   Aparicio, José R ^a   Ruiz, Francisco A ^a   Martínez, Juan ^a   Casellas, Juan A ^a   Soto, José L ^b   Zapater, Pedro ^a   Jover, Rodrigo ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b Elche University Hospital   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; KRAS PROTEIN, HUMAN; PROTEIN P21;

ADENOMA; ADULT; ADVANCED CANCER; AGE; ARTICLE; CANCER RISK; CARCINOGENESIS; COLON POLYP; DISEASE ASSOCIATION; DISEASE COURSE; DYSPLASIA; FEMALE; GENE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MIDDLE AGED; ONCOGENE BRAF; ONCOGENE K RAS; RETROSPECTIVE STUDY; SEX; SOMATIC MUTATION; SPLENIC FLEXURE; COLONIC POLYPS; COLORECTAL TUMOR; COMPLICATION; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; MUTATION; PATHOLOGY; SECOND CANCER;

COLONIC POLYPS; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASMS, SECOND PRIMARY; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS P21(RAS); RETROSPECTIVE STUDIES;

EID: 85029896254     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0184937     Document Type: Article

References (50)

1. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007; 50: 113–30. https://doi.org/10.1111/j.1365-2559.2006.02549.x PMID: 17204026
2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990; 61: 759–67. PMID: 2188735
3. Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology. 2008; 135: 1079–99. https://doi.org/10.1053/j.gastro.2008.07.076 PMID: 18773902
4. Jass JR. Serrated adenoma and colorectal cancer. J Pathol. 1999; 187: 499–502. https://doi.org/10.1002/(SICI)1096-9896(199904)187:5<499::AID-PATH309>3.0.CO;2-B PMID: 10398112
5. Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol. 2011; 42: 1–10. https://doi.org/10.1016/j.humpath.2010.06.002 PMID: 20869746
6. Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013; 369: 1095–105. https://doi.org/10.1056/NEJMoa1301969 PMID: 24047059
7. Bond JH. Colon polyps and cancer. Endoscopy. 2003; 35: 27–35. https://doi.org/10.1055/s-2003-36410 PMID: 12510223
8. Imperiale TF, Ransohoff DF. Understanding differences in the guidelines for colorectal cancer screening. Gastroenterology. 2010; 138: 1642–7 e1. https://doi.org/10.1053/j.gastro.2010.03.027 PMID: 20302867
9. Carethers JM. Biomarker-directed Targeted Therapy in Colorectal Cancer. J Dig Cancer Rep. 2015; 3: 5–10. PMID: 26609516
10. Kressner U, Bjorheim J, Westring S, Wahlberg SS, Pahlman L, Glimelius B, et al. Ki-ras mutations and prognosis in colorectal cancer. Eur J Cancer. 1998; 34: 518–21. PMID: 9713302
11. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002; 417: 949–54. https://doi.org/10.1038/nature00766 PMID: 12068308
12. Hamilton SR, Bosman FT, Boffetta P, Ilyas M, Morreau H, Nakamura SI. Carcinoma of the colon and rectum. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO Classification of Tumours of the digestive system. Lyon: International Agency for Research on Cancer (IARC); 2010. pp. 134–46.
13. Snover D, Ahnen DJ, Burt RW, Odze RD. Serrated polyps of the colon and rectum and serrated polyposis. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO Classification of Tumours of the Digestive System. 4 ed. Lyon, France: IARC Press; 2010. pp. 160–5.
14. Burt RW, Barthel JS, Dunn KB, David DS, Drelichman E, Ford JM, et al. NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw. 2010; 8: 8–61. PMID: 20064289
15. Erichsen R, Baron JA, Hamilton-Dutoit SJ, Snover DC, Torlakovic EE, Pedersen L, et al. Increased Risk of Colorectal Cancer Development Among Patients With Serrated Polyps. Gastroenterology. 2016; 150: 895–902 e5. https://doi.org/10.1053/j.gastro.2015.11.046 PMID: 26677986
16. Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012; 107: 1315–29; quiz 4, 30. https://doi.org/10.1038/ajg.2012.161 PMID: 22710576
17. Benlloch S, Paya A, Alenda C, Bessa X, Andreu M, Jover R, et al. Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology. J Mol Diagn. 2006; 8: 540–3. https://doi.org/10.2353/jmoldx.2006.060070 PMID: 17065421
18. Guarinos C, Sanchez-Fortun C, Rodriguez-Soler M, Perez-Carbonell L, Egoavil C, Juarez M, et al. Clinical subtypes and molecular characteristics of serrated polyposis syndrome. Clin Gastroenterol Hepatol. 2013; 11: 705–11; quiz e46. https://doi.org/10.1016/j.cgh.2012.12.045 PMID: 23376323
19. Phipps AI, Limburg PJ, Baron JA, Burnett-Hartman AN, Weisenberger DJ, Laird PW, et al. Association between molecular subtypes of colorectal cancer and patient survival. Gastroenterology. 2015; 148: 77–87 e2. https://doi.org/10.1053/j.gastro.2014.09.038 PMID: 25280443
20. Sinicrope FA, Shi Q, Smyrk TC, Thibodeau SN, Dienstmann R, Guinney J, et al. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes. Gastroenterology. 2015; 148: 88–99. https://doi.org/10.1053/j.gastro.2014.09.041 PMID: 25305506
21. Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, Cox C, et al. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Research. 2002; 62: 6451–5. PMID: 12438234
22. Spring KJ, Zhao ZZ, Karamatic R, Walsh MD, Whitehall VL, Pike T, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology. 2006; 131: 1400–7. https://doi.org/10.1053/j.gastro.2006.08.038 PMID: 17101316
23. Jass JR, Baker K, Zlobec I, Higuchi T, Barker M, Buchanan D, et al. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a’fusion’ pathway to colorectal cancer. Histopathology. 2006; 49: 121–31. https://doi.org/10.1111/j.1365-2559.2006.02466.x PMID: 16879389
24. Lorentzen JA, Grzyb K, De Angelis PM, Hoff G, Eide TJ, Andresen PA. Oncogene Mutations in Colorectal Polyps Identified in the Norwegian Colorectal Cancer Prevention (NORCCAP) Screening Study. Clinical Medicine Insights Pathology. 2016; 9: 19–28. https://doi.org/10.4137/CPath.s40143 PMID: 27656095
25. Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut. 2004; 53: 1137–44. https://doi.org/10.1136/gut.2003.037671 PMID: 15247181
26. Yang HM, Mitchell JM, Sepulveda JL, Sepulveda AR. Molecular and histologic considerations in the assessment of serrated polyps. Arch Pathol Lab Med. 2015; 139: 730–41. https://doi.org/10.5858/arpa. 2014-0424-RA PMID: 26030242
27. Chen H, Lefferts JA, Schwab MC, Suriawinata AA, Tsongalis GJ. Correlation of polypoid colorectal ade-nocarcinoma with pre-existing adenomatous polyps and KRAS mutation. Cancer Genet. 2011; 204: 245–51. https://doi.org/10.1016/j.cancergen.2011.04.002 PMID: 21665177
28. Ishii T, Notohara K, Umapathy A, Mallitt KA, Chikuba H, Moritani Y, et al. Tubular adenomas with minor villous changes show molecular features characteristic of tubulovillous adenomas. Am J Surg Pathol. 2011; 35: 212–20. https://doi.org/10.1097/PAS.0b013e318205df20 PMID: 21263241
29. Maltzman T, Knoll K, Martinez ME, Byers T, Stevens BR, Marshall JR, et al. Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics. Gastroenterology. 2001; 121: 302–9. PMID: 11487539
30. Yadamsuren EA, Nagy S, Pajor L, Lacza A, Bogner B. Characteristics of advanced- and non advanced sporadic polypoid colorectal adenomas: correlation to KRAS mutations. Pathol Oncol Res. 2012; 18: 1077–84. https://doi.org/10.1007/s12253-012-9547-3 PMID: 22729813
31. Yamane LS, Scapulatempo-Neto C, Alvarenga L, Oliveira CZ, Berardinelli GN, Almodova E, et al. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy. Oncol Rep. 2014; 32: 1419–26. https://doi.org/10.3892/or.2014.3338 PMID: 25050586
32. Nusko G, Sachse R, Mansmann U, Wittekind C, Hahn E. K-RAS-2 gene mutations as predictors of metachronous colorectal adenomas. Scandinavian journal of gastroenterology. 1997; 32: 1035–41. PMID: 9361177
33. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012; 143: 844–57. https://doi.org/10.1053/j.gastro.2012.06. 001 PMID: 22763141
34. Hassan C, Quintero E, Dumonceau J-M, Regula J, Brandão C, Chaussade S, et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2013; 45: 842–64. https://doi.org/10.1055/s-0033-1344548 PMID: 24030244
35. Saini SD, Kim HM, Schoenfeld P. Incidence of advanced adenomas at surveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review. Gastrointest Endosc. 2006; 64: 614–26. https://doi.org/10.1016/j.gie.2006.06.057 PMID: 16996358
36. Martinez ME, Thompson P, Messer K, Ashbeck EL, Lieberman DA, Baron JA, et al. One-year risk for advanced colorectal neoplasia: U.S. versus U.K. risk-stratification guidelines. Ann Intern Med. 2012; 157: 856–64. https://doi.org/10.7326/0003-4819-157-12-201212180-00005 PMID: 23247939
37. Janjua HG, Hogdall E, Linnemann D. Hyperplastic polyps of the colon and rectum—reclassification, BRAF and KRAS status in index polyps and subsequent colorectal carcinoma. APMIS. 2015; 123: 298–304. https://doi.org/10.1111/apm.12355 PMID: 25708741
38. Ogino S, Chan AT, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut. 2011; 60: 397–411. https://doi.org/10.1136/gut.2010.217182 PMID: 21036793
39. Ogino S, Nishihara R, VanderWeele TJ, Wang M, Nishi A, Lochhead P, et al. Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine. Epidemiology. 2016; 27: 602–11. https://doi.org/10.1097/EDE. 0000000000000471 PMID: 26928707
40. Guinney J, Dienstmann R, Wang X, de Reynies A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015; 21: 1350–6. https://doi.org/10.1038/nm.3967 PMID: 26457759
41. Robertson DJ, Lieberman DA, Winawer SJ, Ahnen DJ, Baron JA, Schatzkin A, et al. Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut. 2014; 63: 949–56. https://doi.org/10.1136/ gutjnl-2012-303796 PMID: 23793224
42. le Clercq CM, Bouwens MW, Rondagh EJ, Bakker CM, Keulen ET, de Ridder RJ, et al. Postcolono-scopy colorectal cancers are preventable: a population-based study. Gut. 2014; 63: 957–63. https://doi.org/10.1136/gutjnl-2013-304880 PMID: 23744612
43. Rosty C, Hewett DG, Brown IS, Leggett BA, Whitehall VL. Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management. J Gastroenterol. 2013; 48: 287–302. https://doi.org/10.1007/s00535-012-0720-y PMID: 23208018
44. Oono Y, Fu K, Nakamura H, Iriguchi Y, Yamamura A, Tomino Y, et al. Progression of a sessile serrated adenoma to an early invasive cancer within 8 months. Dig Dis Sci. 2009; 54: 906–9. https://doi.org/10.1007/s10620-008-0407-7 PMID: 18688718
45. Anderson JC. Pathogenesis and management of serrated polyps: current status and future directions. Gut Liver. 2014; 8: 582–9. https://doi.org/10.5009/gnl14248 PMID: 25368744
46. le Clercq CM, Winkens B, Bakker CM, Keulen ET, Beets GL, Masclee AA, et al. Metachronous colorectal cancers result from missed lesions and non-compliance with surveillance. Gastrointest Endosc. 2015; 82: 325–33 e2. https://doi.org/10.1016/j.gie.2014.12.052 PMID: 25843613
47. Pohl H, Srivastava A, Bensen SP, Anderson P, Rothstein RI, Gordon SR, et al. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology. 2013; 144: 74–80 e1. https://doi.org/10.1053/j.gastro.2012.09.043 PMID: 23022496
48. Holme O, Bretthauer M, Eide TJ, Loberg EM, Grzyb K, Loberg M, et al. Long-term risk of colorectal cancer in individuals with serrated polyps. Gut. 2015; 64: 929–36. https://doi.org/10.1136/gutjnl-2014-307793 PMID: 25399542
49. Bouwens MW, Riedl RG, Bosman FT, Driessen A, Sanduleanu S. Large proximal serrated polyps: natural history and colorectal cancer risk in a retrospective series. J Clin Gastroenterol. 2013; 47: 734–5. https://doi.org/10.1097/MCG.0b013e318293a656 PMID: 23751843
50. Schreiner MA, Weiss DG, Lieberman DA. Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology. 2010; 139: 1497–502. https://doi.org/10.1053/j.gastro.2010.06.074 PMID: 20633561